Abstract
Abatacept (Orencia®) is an injectable, synthetic (man-made) soluble fusion protein that consists of the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) linked to the modified Fc portion of human immunoglobulin G1 (IgG1). Abatacept is produced by recombinant DNA technology in a mammalian cell expression system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag/Wien
About this chapter
Cite this chapter
(2009). Abatacept. In: Rovenský, J., Payer, J. (eds) Dictionary of Rheumatology. Springer, Vienna. https://doi.org/10.1007/978-3-211-79280-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-211-79280-3_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-68584-6
Online ISBN: 978-3-211-79280-3
eBook Packages: MedicineMedicine (R0)